RNA: New Antimicrobial Strategies
$881,227ZIAFY2019HLNIH
National Heart, Lung, And Blood Institute
Investigators
Linked publications & trials
Paper 38992441Paper 37312842Paper 37257453Paper 34845084Paper 32795418Paper 30940810Paper 30929236Paper 27841871Paper 26638992Paper 24768306Paper 24318897Paper 23578404Paper 21930586Paper 21615107
Abstract
In the past year, two lines of research yielded publications. In collaboration with Dr. Piszczek (NHLBI Biophysics Core) we have determined best-practice methods for the analysis of riboswitch-small molecule interactions with the first-principles method isothermal calorimetry. In collaboration with Dr. Schneekloth (NCI) we have combined high-throughput small molecule screening, X-ray crystallography, and structure-guided design to create synthetic ligands for the bacterial PreQ1 riboswitch. This study produced lead compounds with biochemical activity to be elaborated further, and also yielded insights into the mechanism of action of this important bacterial gene-regulatory RNA.
View original record on NIH RePORTER →